Answers are grounded in this paper and cite their sources.
Background Bone marrow aspiration (BMA) is performed to determine bone marrow involvement (BMI) in paediatric non-Hodgkin lymphoma (NHL). In adult patients, non-invasive imaging with positron emission tomography ([ 18 F]FDG PET-CT) is used instead of BMA. This is not the case in paediatric NHL. The study's primary objective is to compare the agreement of imaging ([ 18 F]FDG PET-CT and WB-DW-MRI) versus BMA in paediatric NHL for BMI assessment, while also exploring the impact on tumour staging and subtype-specific differences. Procedure This single-center retrospective review included children diagnosed with NHL between 2018-2022, 0-18 years, received a BMA, an [ 18 F]FDG PET-CT and/or WB-DW-MRI before treatment. Data analysis included calculating sensitivity (SN), specificity (SP), positive predictive value (PPV), negative predictive value (NPV), and accuracy. BMA was considered the gold standard. Results In 79 patients (mean age 10 years, 76% male), combined [ 18 F]FDG PET-CT and WB-DW-MRI was concordant with BMA in 52 patients (66%). Combined imaging techniques demonstrated high SN, SP, NPV, and accuracy (respectively 80%, 73%, 97%, and 74%) for BMI. Imaging-based approach led to stage IV reclassification in 17 patients. Accuracy in assessing BMI varied across lymphoma subtypes. Conclusions Compared to BMA, [ 18 F]FDG PET-CT, and WB-DW-MRI were highly accurate in determining BMI in paediatric NHL with notable high NPVs. These imaging techniques offer viable alternatives for BMA in the evaluation of BMI.
No takes yet. Share an insight, caveat, or question.
Kuiper et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: